MIR556
gene geneOn this page
Also known as hsa-mir-556
Summary
MIR556 (microRNA 556, HGNC:32812) is a microRNA gene on chromosome 1q23.3.
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Source: NCBI Gene 693141 — RefSeq curated summary.
At a glance
- Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32812 |
| Approved symbol | MIR556 |
| Name | microRNA 556 |
| Location | 1q23.3 |
| Locus type | RNA, micro |
| Status | Approved |
| Aliases | hsa-mir-556 |
| Ensembl gene | ENSG00000207729 |
| Ensembl biotype | miRNA |
| Entrez | 693141 |
| RNAcentral | URS00006C3A3C — miRNA, 95 nt, 4 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 miRNA
ENST00000384996
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000384996 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001500003 | 162342546 | 162342640 |
Expression profiles
Bgee: expression breadth broad, 67 present calls, max score 79.85.
Top tissues by expression
67 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| endometrium | UBERON:0001295 | 79.85 | gold quality |
| monocyte | CL:0000576 | 79.63 | gold quality |
| heart | UBERON:0000948 | 76.20 | gold quality |
| liver | UBERON:0002107 | 75.45 | gold quality |
| adrenal tissue | UBERON:0018303 | 73.95 | gold quality |
| gastrocnemius | UBERON:0001388 | 73.02 | gold quality |
| bone marrow | UBERON:0002371 | 72.69 | gold quality |
| tibial artery | UBERON:0007610 | 71.84 | gold quality |
| body of pancreas | UBERON:0001150 | 71.44 | gold quality |
| kidney | UBERON:0002113 | 70.75 | gold quality |
| putamen | UBERON:0001874 | 70.74 | gold quality |
| body of stomach | UBERON:0001161 | 70.22 | gold quality |
| right lobe of liver | UBERON:0001114 | 70.04 | gold quality |
| right atrium auricular region | UBERON:0006631 | 70.04 | gold quality |
| blood | UBERON:0000178 | 69.63 | gold quality |
| right adrenal gland | UBERON:0001233 | 69.34 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 69.26 | gold quality |
| stomach | UBERON:0000945 | 69.16 | gold quality |
| colon | UBERON:0001155 | 68.80 | gold quality |
| granulocyte | CL:0000094 | 68.73 | gold quality |
| transverse colon | UBERON:0001157 | 68.48 | gold quality |
| lung | UBERON:0002048 | 68.19 | gold quality |
| minor salivary gland | UBERON:0001830 | 68.04 | gold quality |
| ascending aorta | UBERON:0001496 | 66.92 | gold quality |
| omental fat pad | UBERON:0010414 | 66.60 | gold quality |
| skin of abdomen | UBERON:0001416 | 66.37 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 66.05 | gold quality |
| hypothalamus | UBERON:0001898 | 65.78 | gold quality |
| body of uterus | UBERON:0009853 | 65.78 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 65.64 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.82 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 17)
- miR-556-5p functions as an onco-miRNA and participates in prostate cancer carcinogenesis by suppressing PPP2R2A expression. (PMID:26297546)
- Results suggest that microRNAs miR-221-5p, miR-380-3p, miR-556-5p, miR-758-3p and miR-3074-3p are potential diagnostic biomarkers of lupus nephritis in patients with systemic lupus erythematosus (SLE). (PMID:27835701)
- These findings suggest that DAB2IP is a direct target of miRNA-556-3p, and endogenous miRNA-556-3p expression shows inverse correlation with simultaneous DAB2IP expression in bladder cancer (BC)tissues and cells. miRNA-556-3p functions as a tumor promoter in tumorigenesis and metastasis of BC by targeting DAB2IP (PMID:28440444)
- this study indicated that a functional polymorphism of GSTM3 -rs1055259 reduced susceptibility of clear cell renal cell carcinoma in the Chinese population. It influenced GSTM3 protein synthesis by interfering miR-556 binding, subsequently suppressed ROS activity and clear cell renal cell carcinoma progression. (PMID:29569387)
- MicroRNA-556-3p blocked the translation of DAB2IP at mRNA level by directly binding to 3’UTR of DAB2IP, enhancing the proliferation of esophageal tumor cells. (PMID:30402845)
- SNHG1/miR-556-5p/TCF12 feedback loop enhances the tumorigenesis of meningioma through Wnt signaling pathway. (PMID:31692066)
- Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis. (PMID:31931771)
- Down-regulation of miR-556-3p inhibits hemangioma cell proliferation and promotes apoptosis by targeting VEGFC. (PMID:33040837)
- Targeting a novel hsa_circ_0000520/miR-556-5p/NLRP3 pathway-mediated cell pyroptosis and inflammation attenuates ovalbumin (OVA)-induced allergic rhinitis (AR) in mice models. (PMID:34028600)
- CircDIP2C ameliorates oxidized low-density lipoprotein-induced cell dysfunction by binding to miR-556-5p to induce TET2 in human umbilical vein endothelial cells. (PMID:34147657)
- Knock-down of microRNA miR-556-5p increases cisplatin-sensitivity in non-small cell lung cancer (NSCLC) via activating NLR family pyrin domain containing 3 (NLRP3)-mediated pyroptotic cell death. (PMID:34488537)
- Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer. (PMID:34781990)
- N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop. (PMID:36700472)
- Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma. (PMID:37005879)
- Down-regulation of long noncoding RNA HULC inhibits the inflammatory response in ankylosing spondylitis by reducing miR-556-5p-mediated YAP1 expression. (PMID:37525215)
- circSLCO1B7 suppresses the malignant progression of hepatocellular carcinoma via the miR-556-3p/DAB2IP axis. (PMID:38015711)
- Circular RNA circ_0096041 promotes osteosarcoma cell proliferation and migration via sponging miR-556-5p and regulating LIN28A expression. (PMID:38430033)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.